Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

CanniMed Therapeutics Inc buy dokem

CanniMed Therapeutics Inc
Start price
€17.00
15.01.18 / 50%
Target price
€19.00
18.01.18
Performance (%)
23.53%
End price
€21.00
18.01.18
Summary
This prediction ended on 18.01.18 with a price of €21.00. The prediction had a final performance of 23.53%. dokem has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
CanniMed Therapeutics Inc - - - -
iShares Core DAX® -1.283% 4.209% 7.084% 64.252%
iShares Nasdaq 100 -3.338% -1.744% 26.177% 84.969%
iShares Nikkei 225® -4.286% -1.621% 44.320% 79.253%
iShares S&P 500 -2.311% -0.096% 20.823% 68.079%

Comments by dokem for this prediction

In the thread CanniMed Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 23.53%
Target price 19.000
Change
Ends at 18.01.18

dokem stimmt dem Sentiment von 'Sell' nicht zu

dokem stimmt am 14.01.2018 dem Sell-Gesamtsentiment mit dem Kursziel 14.8€ nicht zu.

dokem 
0
Report Share
15.01.18
Prediction Buy
Perf. (%) 23.53%
Target price 19.000
Change
Ends at 18.01.18

(Zielkurs erreicht)

dokem 
0
Report Share
18.01.18